Timing the decline: Cellular circadian rhythms and Alzheimer’s disease
Proceedings of the National Academy of Sciences · 14.04.2026 · 123 (15)
DOI: 10.1073/pnas.2604049123 ↗Kurz gefasst
Kommentar in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 06.04.2026. Verfasst von Christopher S Colwell. Beteiligte Einrichtung: Department of Psychiatry and Biobehavioral Sciences, Semel Institute, University of California Los Angeles, Los Angeles, CA. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Themen: Demenz
Abstract (Originalsprache)
A growing body of work links circadian disruption to aging and neurodegenerative disease, yet a central question has remained unresolved: Do altered daily rhythms merely reflect disease and lifestyle, or do they reveal intrinsic clock prop - erties that shape vulnerability to brain aging? In PNAS, Roh et al. (1) show that circadian timing measured directly in patient - derived skin fibroblasts associates with Alzheimer’s disease (AD) pathology, brain atrophy, cognition
Autor:innen und Institutionen
- Department of Psychiatry and Biobehavioral Sciences, Semel Institute, University of California Los Angeles, Los Angeles, CA.
ORCID-Profile: Christopher S Colwell
Zitieren
APA
Colwell, C. S. (2026). Timing the decline: Cellular circadian rhythms and Alzheimer’s disease. Proceedings of the National Academy of Sciences, 123(15). https://doi.org/10.1073/pnas.2604049123
Vancouver
Colwell CS. Timing the decline: Cellular circadian rhythms and Alzheimer’s disease. Proceedings of the National Academy of Sciences. 2026;123(15). doi:10.1073/pnas.2604049123
BibTeX
@article{Colwell2026,
author = {Colwell, Christopher S},
title = {Timing the decline: Cellular circadian rhythms and Alzheimer’s disease},
journal = {Proceedings of the National Academy of Sciences},
year = {2026},
volume = {123},
number = {15},
doi = {10.1073/pnas.2604049123}
}
EUVIMED